Stay updated with breaking news from Chand jagpal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's proprietary manufacturing methodology, developed and validated in-house at Albert Labs' Vancouver facility, facilitates the production and scaling of highly potent yields of its KRN Active Pharmaceutical Ingredient. ....
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB. ....